Article
Rifampicin markedly decreases the exposure to oral and intravenous tramadol.
European journal of clinical pharmacology - 1 Jun 2013
Saarikoski Tuukka, Saari Teijo I, Hagelberg Nora M, Neuvonen Mikko, Neuvonen Pertti J, Scheinin Mika, Olkkola Klaus T, Laine Kari
Abstract excerpt
PURPOSE: Tramadol is mainly metabolized by the cytochrome P450 (CYP) 2D6, CYP2B6 and CYP3A4 enzymes. The aim of this study was to evaluate the effect of enzyme induction with rifampicin on the pharmacokinetics and pharmacodynamics of oral and intravenous tramadol. METHODS: This was a randomized p...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
